These findings are consistent with our concept that Zip1, and now Zip2 and Zip3, are tumor-suppressor genes in prostate cancer; and provide the explanation and genetic/molecular/metabolic mechanism for the virtual absence of malignant prostate glands that retain the high zinc levels that characterize the normal glands. The gene discussed is SLC39A2; the disease is prostate carcinoma.